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Summary
This study was designed to investigate whether follicular dendritic cells (FDC) can activate B
cells to a statein which they can function as effective antigen-presenting cells (APC). High buoyant
density (i.e., resting) B cells specific for 2,4-dinitro-fluorobenzene (DNP) were incubated with
DNP-ovalbumin (OVA) bearing FDC, after which their capacity to process and present to an
OVA-specific T cell clone was assessed. The efficacies ofalternative sources ofantigen and activation
signals in the induction of B cell APC function were compared with those provided by FDC.
Only FDC and Sepharose beads coated with anti-immunoglobulin (1g)tt monoclonal antibody
provided the necessary stimulus. FDC carrying inappropriate antigens also induced B cell APC
function in the presence of exogenous DNP-OVA. However, in circumstances where soluble
DNP-OVA was limiting, FDC bearing complexes containing DNP, which could crosslink B
cell Ig receptors, induced the most potent APC function. Analysis by flow cytometry revealed
that within 24 h of coculture with FDC, a significant percentage of B cells increased in size
and expressed higher levels of major histocompatibility complex class II. By 48 h, an upregulation
of the costimulatory molecule, B7/BB1, occurred, but only when exposed to the FDC bearing
DNP. Taken together, the results demonstrate that FDC have the capacity to activate resting
B cells to a state in which they can function as APC for T cells. The stimuli that FDC provide
may include: (a) an antigen-dependent signal that influences the upregulation of B7/BB1; and
(b) possibly a signal independent ofcrosslinking mIg that results in Ig internalization. The relevance
of these findings to the formation of germinal centers and maintenance of the humoral response
is discussed.
G
erminal centers are sites of antigen-driven B cell prolifer-
ation that can develop in two circumstances: an anti-
genic challenge (1) and depletion ofcirculating antibody levels
(2). They arisewithin primary follicles, becoming a zone where
B cells divide rapidly (3, 4), switch their Ig isotypes (5, 6),
and undergo affinity maturation (7-9). The net result is the
generation of an antigen-experienced, memory B cell popu-
lation (10, 11) and the induction of antigen-specific plasma
cells (2, 12, 13).
Formation of germinal centers is at leastin part dependent
upon the presence of immune complexes (10). These mole-
cules are trapped and retained by follicular dendritic cells
(FDC)t that reside in primary follicles and the light zone
1 Abbreviations used in this paper: DNP, 2,4-dinitro-fluorobenzene; FDC,
follicular dendritic cells.
of germinal centers (14, 15). After an antigen insult, the set
of events giving rise to a germinal center involves a deposi-
tion of antigen in the form of immune complexes on FDC,
followed by contact, internalization, processing, and presen-
tation of the immunogen by specific B cells to T helper cells
in the area (16-18). At this point, the B cells begin to divide
and go on to form the germinal center.
In addition to an antigenic challenge, germinal centers are
also generated after a decrease in circulating Ab titers. Taking
at least a third of a mouse's volume of blood induces ger-
minal center formation in association with antigen-specific
plasma cells (2). During this reaction, the B cell proliferation
observed may aid in the maintenance of circulating memory
B cell clones. Periodic contact with the antigen retained by
FDC seems necessary for maintaining memory since trans-
ferring cells from an immune animal to a naive one in the
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within 12 wk (19). However, providingantigenthat becomes
localized on FDC will maintain the memory response over
much longer periods. Under physiological conditions when
antibody levels fall, the exposure of antigenic epitopes on FDC
and the subsequent B cell proliferation observed may repre-
sent the mechanism by which memory B cell clones are cy-
clically maintained (13, 20, 21).
In several experimental systems, resting B cells are poor
at processing and presenting antigen to T cells (22-26). As
this study and those of others have previously shown, a
monovalent antigenic signal appears to be insufficient for B
cell activation (27-30). Crosslinking membrane (m)Ig is re-
quired for such an effect (31). How then does such cross-
linkingoccurin vivo; do specialized cells existthat "present"
antigen to resting B cells, be they naive or memory B cells?
FDC are obvious candidates for this function since their
cardinal feature is to trap and retain unprocessed antigen for
months on the extracellular surface of theirplasma membrane
(14, 20). While we have shown that antigen-specific B cells
can obtain antigen from FDC and subsequently process and
present the antigen (17, 18), it is still not known if this pro-
cess can induce resting B cells to become competent antigen
presenters. In this report, we demonstrate that FDC have
the capacity to induce a variety of phenotypic changes in B
cells that lead to this activation state. While the induction
of some changes in B cell physiology appears to be antigen
independent, the induction of optimal B cell APC function
is generated after an antigen-specific interaction with FDC.
Materials and Methods
Animals.
￿
TheSp6 transgenic mouse line was generated by in-
troducinga p.,K constructfrom an antiTNPhybridomaofBALB/c
origin into the germline of an outbred mouse (32). The line was
maintained on a BALB/c background by Dr. L. Forniat theBasel
Institute for Immunology. Transgenic progeny were identified by
theirhigh titers of circulating anti-TNP antibodies as assessed by
standard ELISA techniques. Mice were screened after 4 wk of age
and used up to 6 mo old.
Female C57BL/6 mice were obtained from Iffa-Credo (L' Ar-
brasle, France) andused between theages of 1 and6 mo. C57BL/6
mice rendered 11Adeficient by gene targetingwere kindly provided
by Drs. M. Kopf andG. LeGros (Max Planck Institute, Freiburg,
Germany) (33).
Immunizations.
￿
For targeting of antigen to FDC in vivo, cir-
culating specific antibody was initially generatedby giving apri-
mary immunization behind the neck with antigen precipated in
aluminium sulfate containing 5 x 108 heat-killed Bordetella pertussis
(20p.g/0.1 ml permouse). 2-6 wk later, themice received a second
injection ofthe same antigen subcutaneously in each limb (10NAg/50
id perlimb), whichlocalized on theFDCwithin 24 h in theform
of immune complexes.
The antigens used included OVA (fraction V, A-5503; Sigma
Chemical Co., St. Louis, MO), KLH (374817; Calbiochem-Behring
Corp., LaJolla, CA), and2,4-dinitro-fluorobenzene (DNP, D-1529;
Sigma Chemical Co.). OVA or KLH were coupled to DNP as pre-
viously described (34, 35).
PreparingIsolatedFDC.
￿
Thelow density, nonadherent cell frac-
tion wasobtained form thelymphnodesofimmune C57BL/6mice
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2 dafterwholebody irradiation (600 rad, cesium source). Theradi-
ation treatment is an essential step in order to isolate FDC with
far fewer contaminating lymphocytes. C57BL/6 mice were used
as the source of FDC in order to avoid antigen presentation by
cells in this population (which are H-2b) to the H-2d-restricted
T cell clones. The association of B cells intertwined within the
FDC'sdendriticprocessesmakes standard depletion techniques un-
successful (18). Once excised from the mice, the collagen of the
tissue was digested using an enzyme cocktail according to the
method developed by Schnizlein et al. (36) with modifications
reported elsewhere (35). Enrichment steps were done as specified
by Schnizlein usingcontinuous Percoll gradients andan adherence
step. To deplete T cells, the preparations were then treated with
antiThy-1 (T24)-, anti-CD4 (GK1.5)-, and anti-CD8 (53.6.7)-
coated magnetic Dynabeads(Dynal A.S., Oslo, Norway)according
to the manufacturer's specifications. These steps lead to acell sus-
pensioncontaining between25 and40% FDCas quantitated using
the rat anti-mouse FDC-specific mAb antibody, FDC-Ml (35),
<1% CD4- or C138-positive cells, and 50-60% Ig-positive cells
(which would include the 25-40% immune complexretaining FDC
and with the 20-25% remaining being B cells). The percentage
ofundefinedcellsupon culturingfor several days have themorpho-
logical characteristics of fibroblasts. A small percentage of these
are also macrophages, some of which contain tingible bodies (i.e.,
apoptoticlymphocytes). Forthe Tcell proliferation assays, theiso-
lated FDC preparations were irradiated with 1,000 radbefore cul-
turing. In all procedures and experiments, the complete medium
used was IMDM containing 5% FCS and supplemented with 5
x 10-s M mercaptoethanol plus penicillin/streptomycin.
Preparing the Non-FDC Population, Macrophages, and Dendritic
Cells. The cellsdefined as non-FDCwere generatedusingapro-
tocolin whichthe tissue is mechanically disruptedinstead ofenzy-
matically digested. Due to their extensive network of dendritic
processes, FDC do not survive this harsh break-up of the tissue
(37). The resulting non-FDC-containing single-cell suspension was
then treated in parallel with thecells obtained using the enzymes
(i.e., percoll gradient sedimentation, 1-h adherence, T cell deple-
tion, and irradiation).
The macrophage and dendritic cell populations were obtained
from thecells left behind afterwashingof the tissue culture plate
during the adherence step of theFDCisolation procedure. Gentle
removalusingasingle sweeping stroke ofarubber policemanyielded
>90% viable cells.
Preparing Resting and ActivatedB Cells.
￿
SP6mice transgenic for
p.,u Ig isotype specific for TNP or DNP were used as the source
ofantigen-specific B cells(32).Single-cell suspensions were gener-
ated from theirspleens by passing thetissue through a nylon mesh.
Afterlysis of red bloodcells, cells were fractionated into a resting
or an activated population by buoyancy using discontinuous Per-
coll density gradients. The resting, high buoyant density B cells
were isolated at the 1.079-1.085-g/cc interface and the activated,
low buoyant density cells between 1.06 and 1.07 g/cc (38). The
high density fraction was then depleted ofT cells using a cocktail
ofThy-1(T24)-, CD4(GK1.5)-, andCD8(53.6.75)-coated mag-
netic Dynabeads. The resulting population as determined using
aFRCS®(BectonDickinson & Co., Mountain View, CA)was<1%
positive for CD4 or CD8 cells (mAbs L3T4 and Ly2, respectively;
Caltag Laboratories, SanFrancisco, CA), and 90-95% positive for
sIg (F[ab'12 fragments of rat anti-mouse IgG, H and L chain
specific;JacksonImmunoresearch Labs., Inc., West Grove, PA)and
IE (mAb 14.4.4; American Type Culture Collection, Rockville,
MD).
The activated, low density population was incubated for 1 hat 37°C to remove adherent cells such as macrophages and den-
dritic cells. By this procedure, the cells were 85-90% positive for
sIg and B220 (mAb 14.8 ; American Type Culture Collection) and
90-95% positive for IE . Although the low density fraction was
highly enriched for activated B cells, a mixture of plasmablasts,
plasma cells, and fibroblasts contributed to the remaining Ia-negative
percentage of cells. The remaining la-positive, sIg/B220-negative
fraction reflected a macrophage contribution as assessed by mor-
phology and possibly dendritic cells. Since this population served
only as a comparative positive control for APC function, care was
not taken to remove every non-B cell. For the T cell proliferation
assays (seebelow), theB cell populations were added to cellculture
wells with the appropriate combinations of the other cell types
or antigens, and then irradiated with 1,000 rad before adding the
OVA-specific T cell (Tova) clones .
Preparation ofImmune Complex orAnti-ic-coatedBeads.
￿
DNP im-
mune mouse serum was incubated with sheep anti-mouse Ig-
coupled magnetic Dynabeads, washed, and then incubated in ei-
ther DNP-OVA or DNRKLH (100,ug of antigen/ml of beads) .
This order of sequential formation of immune complexes on the
beads was specifically conducted in order to : (a) avoid aggregate
formation ; and (b) render inaccessible the Fc portion of the anti-
body. The beads were added to the cultures at a ratio of four beads
per cell .
The rat anti-mouse K light chain mAb, 187 .1, was covalently
linked to Sepharose beads . They were then added to the cultures
at a concentration of x+20 beads/3-4 x 10 5 cells per well .
A polyclonal mouse anti-OVA antiserum was mixed withDNP-
OVA at a concentration that caused formation of precipitated im-
mune complexes. A final concentration of 10 wg/ml ofDNP-OVA
was added to the cultures .
Antigen Presentation Assay Measured as an Index ofT Cell Clone
Proliferation. To assess the antigen presentation capacity ofresting
B cells, 3 x 105 high density B cells were cultured with 3 x 10°
H-21-restricted, OVA-specific T cell clones (a gift from Dr. B .
Stockinger, National Institute for Medical Research, London) in
the presence or absence of a source of antigen and/or activation
signals. Activated, low density cells (3 x 105/well) were used for
comparison and positive controls. FDC, the adherent cell popula-
tion, or the non-FDC containing population were added at a con-
cgntration of 5 x 104 cells/well . DNP-OVA, DNP-KLH, OVA,
or KLH were added at a final concentration of 10 14g/ml (except
in Fig . 1) . As described above, all non-T cell groups were plated
in round-bottomed 96-well plates (Costar, Cambridge, MA) in
IMDM supplemented with 5% FCS, 5 x 10-5 M mercap-
toethanol, and penicillin-streptomycin . Antigen, immune com-
plexes, or coated beads were then added and the plates irradiated
with 1,000 rad. The Tova clones were then added and the plates
placed at 37°C, 5% COZ . After 48 h, 1 1ACi of['H]thymidine was
added to each well and incorporation by the T cell clones was as-
sessed 18 h later in a liquid scintillation counter.
Analysis byFACS®.
￿
To compare forward and side scatter profiles
and levels of expression forMHC class II molecules and theB cell
activation antigen, B7/BBI (39, 40), 3 x 101 resting B cells were
incubated for 24 h with and without 5 x 10°FDC, 20-30 anti-u
beads, or 10 F.g/ml DNP-OVA in U-bottomed wells. Class II was
detected using the 113-specific mouse mAb, 14.4.4, which was bi-
otinylated and then visualized using streptavidin-FITC (Southern
Biotechnology Associates, Birmingham, AL) . SurfaceIgM was de-
tected using a goat anti-mouseIgM conjugated to PE (Southern
Biotechnology Associates) . T cell contamination was assessed using
a FITC-conjugated anti-CD4 (L3T4 ; Caltag Labs ., San Francisco,
CA) and a PE-conjugated anti-CDS (Ly2 ; Caltag Labs .) . B7/BB1
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expression was evaluated using the fusion protein made from the
extracellular portion of the mouse CTLA4 gene and the human
IgG1 constant region . This molecule was generated in house by
Dr. P. Lane and colleagues (Basel Institute for Immunology) and
has been reported to act as a ligand for B7 (41) . The binding of
this protein to the cells was visualized using an F(ab')2 FITC-
conjugated mouse anti-human IgG (Jackson ImmunoResearch
Labs ., Inc .) .
Results
Follicular Dendritic Cells Induce Resting B Cells to Become
EfficientAPC. The ability of resting B cells to process and
present antigen to T-ova clones was compared with that of
activated B cell-enriched populations . To increase the frequency
of DNP-specific B cells, both high (resting) and low buoyant
density (activated) B cells were isolated from spleens ofBALB/c
mice transgenic for a rearranged p,,tc encoding a specificity
for DNP. As previously described (42), up to 50% of the
B cells in these mice bind DNP-conjugated proteins. As il-
lustrated in Table 1, DNP-specific resting B cells were not
able to present solubleDNP-OVA to T-ova clones, while the
activated B cells could.
To determine whether FDC bearing antigen-antibody com-
plexes can induceAPC function in resting B cells,FDC were
isolated from mice that hadbeen hyper-immunized withDNP-
OVA . To eliminate the possibility of direct antigen presenta-
tion to the H-2d-restricted T-ova clone, FDC were isolated
from C57BL/6 mice (H-2b) . As shown in Table 1, DNP-
OVA provided onFDC was acquired, processed, and presented
by both the resting and activated DNP-specific B cells . No
T cell activation was observed in the absence of B cells (T-ova
clone and FDC control wells) .
The possibility that other cell types in the FDC prepara-
tions contributed to this function was tested using cell sus-
pensions devoid of FDC . First, macrophages and dendritic
cells contained in the adherent population were collected or,
alternatively, immune lymph nodes were mechanically dis-
rupted using nylonmesh. This latter procedure destroysFDC
due to the extensive association of their dendritic processes
with the collagen matrix of the organ . As shown in Table
1, T cell proliferation induced by either of these non-FDC
containing groups was no higher than background. In addi-
tion, adding solubleDNP-OVA to these cultures still did not
rescue the APC function of the resting B cells, while the
activated population efficiently used the exogenous antigen
(Table 1) . Taken together, these results confirm the interpre-
tation that it is the FDC component of the population that
provides the observed induction ofAPC function by the resting
B cells.
To assess whether soluble mediators produced by cells in
the FDC preparations were supporting B cell antigen pre-
sentation in this system, FDC isolated from C57BL/6 mice
hyper-immunized with KLH were used . Even in the pres-
ence of exogenous KLH, the FDC-KLH population sup-
ported only 10% of the level of thymidine incorporation by
T-ova clones as compared with that obtained in the presence
ofFDC from DNP-OVA immune mice (Table 1) . Thus, theTable 1 .
￿
Antigen Presentation Capacity of Resting and Activated B cells Stimulated by FDC vs. Non-FDC-containing Populations
B cells, FDCs, MO/DC, and non-FDC populations were irradiated with 1,000 rad; B cells were added at 3 x 10 5/well, T cells at 3 x 10 4/well,
and all others at 5 x 104/well ; [3H]thymidine was added for the last 24 h of a 76-h culture period .
# The activated B cell preparation contained up to 90% B220+ cells and <5% MO and DC .
5 All values represent the average of triplicate wells ; all standard deviations for these values fall within 10% of the mean .
II DNP-OVA : 10 ug/ml of exogenous antigen was added per well .
1 FDC and MO/DC were obtained from mice primed and boosted with DNP-OVA; the B cells, T cells, and MO/DC were then incubated with
or without exogenous DNP-OVA (10 Ag/ml) .
* Non-FDCs were from preparations in which theFDCs were removed . For this, spleens from immune C57BL/6 mice were mechanically disrupted
instead of being enzymatically digested. The resulting non-FDC-containing single-cell suspension was then treated in parallel with the cells obtained
using the enzymes (i .e ., Percoll gradient sedimentation, 1-h adherence, T cell depletion, and irradiation with 1,000 rad) .
## FDC were obtained from mice primed and boosted with KLH ; the B cells, T cells, and FDCs were then incubated with or without exogenous
KLH (10 jug/ml).
T cell proliferation observed in these cultures cannot be at-
tributed to nonspecific soluble mediators derived from cells
in the FDC preparations.
Mimicking the Effects ofFDCRetained Antigen.
￿
The next
series of experiments were designed to characterize the FDC-
derived signal(s) that induce B cell APC function . FDC re-
tain antigen on the extracellular face of their plasma mem-
brane in the form of immune complexes in a spatially or-
dered arrangement . Thus, by presenting a solid matrix of
antigen, one of the essential signals provided by FDC may
be the efficient crosslinking of theB cell's antigen receptors.
Whether or not such crosslinking was sufficient to induce
B cellAPC function was tested by adding beads coated non-
covalently with immune complexes to cultures containing
resting B cells and T-ova clones. As shown in Table 2, the
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Thymidine incorporation"
immune complexes coated to beads did not support the in-
duction of restingB cell APC function, even in thepresence
ofexogenous DNP-OVA. However, the activatedDNP-specific
B cells were able to acquire, process, andpresent DNP-OVA
provided on the beads (Table 2) . In addition, attempts to in-
duce APC function in restingB cells usingDNPconjugated
to irrelevant antigen (KLH), in the presence of exogenous
DNP-OVA, were without success (Table 2) . Precoating cul-
ture wells with DNP-OVA was similarly unsuccessful, and
incubating theimmune complex-coated Dynabeadswith the
FDC and restingB cells didnot inhibit their activation (not
shown) . Crosslinking of mIg using anti-tc-coated beads
efficiently induced theAPCfunction ofrestingB cells in the
presence of exogenous DNP-OVA (Table 2) . In this respect,
anti-tc-coated beads were as efficient as FDC obtained from
Resting B cells
(high density)
Exp . 1 Exp . 2
Activated B cells
(low density)#
Exp. 1 Exp . 2
cpm
Medium alone 433§ 152 467 161
+ DNP-OVA11 365 122 645 171
+ T cells 453 212 1,036 909
+ T cells + DNP-OVA 544 889 30,827 48,192
+ T cells + FDC-D-01 36,049 28,905 24,130 32,948
+ T cells + MO/DC-D-01 522 1,605 4,059 3,729
+ T cells + MO/DC-D-0 + DNP-OVA - 6,157 - 52,711
` + T cells + non-FDC-D-o' 397 - 591 -
+ T cells + non-FDC-D-o + DNP-OVA 1,335 - 16,410 -
+ T cells + FDC-KLH## - 3,271 - 5,480
+ T cells + FDC-,u-H + KLH - 3,622 - 5,723
+ FDC-D-0 758 1,521 729 1,995
+ FDC-KLH 587 143 300 167
Additional controls :
T cells + FDC-D-o 1,066 1,348
T cells + MO/DC 152Table 2 .
￿
Antigen Presentation Capacity ofResting and ActivatedB cells Using Various Sources ofAntigen
DNP-OVA immune mice . These results demonstrate that a
mere solid phase of antigen is not enough to induce B cell
activation. The success of the FDC-associated antigen may
be due to two not mutually exclusive mechanisms : the ar-
rangement of the repeatingimmune complex units on FDC
and other cell surface molecules expressed by FDC.
FDC Provide Signal(s) Independent ofmIg Crosslinking .
￿
To
address the above possibilities, experiments were designed in
order to distinguish the antigen-specific from the antigen-
independent contribution ofFDC. For this, FDC were iso-
lated from mice hyper-immune to either haptenated (DNP-
OVA, DNP-KLH) or nonhaptenated (OVA, KLH) antigens,
and evaluated for their ability to induce the APC function
of resting B cells . As shown in Table 3, in the absence of
exogenousantigen, FDCfromDNP-OVAimmune micewere
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Thymidine incorporation`
Resting B cells
￿
Activated B cells*
(high density)
￿
(low density)
Soluble DNA-OVA§
￿
Soluble DNP-OVAL
B cells and FDCs were irradiated with 1,000 rad before culture; [3H]thymidine was added for the last 24 h of a 76-h culture period .
t The activated B cell preparation contained up to 90% B220+ cells and <5% MO and DC .
SD-O, DNP-OVA : 10 uglml of exogenous antigen were added per well .
II All values represent the average of triplicate wells; all standard deviations for these values fall within 10% of the mean .
IDNP immune mouse serum was incubated with sheep anti-mouse Ig coupled magnetic Dynabeads, washed, and then incubated in either DNP-
OVAorDNP-KLH (100 ug ofantigen/ml ofbeads) .The beads were added to the cultures at a ratio of four beads per cell; the presence ofDNP-KLH
on the beads was confirmed by using them in antigen proliferation assay using the KLH-specific hybrid, 1OH/A .
" The rat anti-mouse K light chain mAb, 187.1, was covalently linked to Sepharose beads, then added to the cultures at a concentration of -20
beads/3 x 10 5 cells .
#Apolyclonal mouse anti-OVA was mixed withDNP-OVA in order to form immune complexes . A final concentration of 10 ug ofDNP-OVA/ml
was added to the cultures .
SS FDC were isolated from DNP-OVA immune C57BL/6 mice.
the only group able to induce theAPC function ofthe resting
B cells. However, in the presence of 10 hg/ml of exogenous
DNP-OVA, all FDCpopulations supported this activity (Table
3) . It is unlikely that non-antigen-specificB cell-FDC inter-
action induced a general, mIg-independent, increase in pinocy-
tosis, since exogenousOVA was not efficiently acquired and
presented by resting B cells in these cultures (Table 3) . In
contrast, the activated B cellspresented the exogenousOVA
as well as theOVAandDNP-OVA retained by theFDCpopu-
lations (Table 3) . These results demonstrate that FDC can
provide resting B cells with signal(s) that are independent
of crosslinking mIg . However, it is not clear whether these
signals are temporally or physically dissociated from those
provided as a consequence of mIg crosslinking by the FDC
in physiological circumstances.
cpm
Antigen on beads
+ DNP-OVA beadsl 765 11 693 31,633 51,376
+ DNP-KLH-beadsl 589 478 2,609 58,975
+ anti-Ig-beads"" 501 16,477 5,847 61,535
Soluble antigens
+DNP-OVA§ 1,393 - 78,666
+ D-0-anti-D-0 complexestt 3,177 - 51,824
FDC-associated antigen
+FDC-D-OSS 16,164 - 18,427
Controls :
B cells alone 211 472 269 341
+ T cells 743 798 1,891 78,041
+ FDC-D-o 920 - 889 -
Additional control :
T cells + FDC-D-o 1,217E
n .
w
Y
F- a
w
Z
O
r x
H
M
DILUTIONSOF DNP-OVA (}lg/ml)
This question was addressed in the next series of experi-
ments. The relative efficiencies ofFDC obtained from animals
hyper-immunized with various antigens were comparedwhen
exogenousDNP-OVA was limiting. FDC bearing DNP-OVA,
DNP-KLH, or KLH were cocultured with the restingB cells
and T-ova clones in the presence of varying concentrations
of DNP-OVA . At high concentrations of exogenous DNP-
OVA (10-100 leg/ml), all of theFDC groups supported com-
Resting B cells (high
density)
￿
Medium
+ T cells +
+ T cells + FDC-DNP-OVA +
+ T cells + FDC-DNP-KLH +
+ T cells + FDC-OVA +
+ T cells + FDC-KLH +
DNP-OVA
B cells +
￿
176
T cells +
￿
175
Activated B cells + T cells +
￿
47,69611
Resting B cells + Tova clone :
NO FDCs
+ FDC-DNP-OVA
+ FDC-DNP-KLH
+ FDC-KLH
DNP-OVA$
FDC-DNP-OVA
945
456
11,390
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parable responses (Fig . 1) . However, when the concentration
ofantigen became limiting, only the B cells interacting with
FDC bearing DNP continued to function as APC forT cell
activation (Fig . 1) .
Taken together, these results indicate that FDC may pro-
vide restingB cells with at least two signals. At low concen-
trations of exogenous DNP-OVA, or in more physiological
circumstances where the only source of antigen is provided
Table 3 .
￿
Antigen Presentation Capacity of Resting B cells after Stimulation by FDC from Either DNROVA, DNP-KLH, OVA,
or KLH-immune Mice
Thymidine incorporation"
Figure 1 .
￿
Limiting the amount of antigen
demonstrates a difference between the FDC
populations . Resting B cells were assessed for
their ability to stimulate the T-ova clone in the
presence or absence ofFDC and 10-fold dilu-
tions of exogenous DNP-OVA . The resting B
cells and Tova clone were cultured with an-
tigen alone (O) or with one of three FDC
populations : (EI), FDC from DNP-OVA im-
mune mice; (A), FDC from DNP-KLH im-
mune mice ; (X), FDC from KLH immune
mice. 1 p,Ci of [3H]thymidine was added per
well at 48 hofa 66-h culture period. Theresting
B cells and variousFDC populations were ex-
posed to 1,000 rad before the addition of the
T-ova clone.
DNP-KLH$ OVA$ KLHt
cpm
FDC-DNP-KLH FDC-OVA FDC-KLH
1,507
￿
993 908
563
￿
404 414
966 12,964 1,346
FDC were isolated from either DNP-OVA, DNP-KLH, OVA, or KLH-immune C57BL/6 mice .
"` B cells and FDCs were irradiated with 1,000 rad before culture . [ 3H]Thymidine was added for the last 24 h of a 76-h culture period .
$ DNP-OVA, DNP-KLH, OVA, or KLH were added at a concentration of 10 pg/well .
§ All values represent the average of triplicate wells; all standard deviations for these values fall within 10% of the mean .
II Activated B cells + T cells : + OVA, 13,900 cpm ; + DNP-KLH, 840 cpm .
518§ 1,820 692 527 544
14,647 38,206 19,802 15,525 16,041
1,640 30,710 1,433 1,913 2,033
2,854 34,227 2,482 1,986 2,979
2,401 29,460 2,145 2,319 3,263in the form ofimmune complexes on FDC, the two signals
are not dissociable. They are comprised of antigen-specific
focusing of theFDC-B cell interaction, which in turn results
in some signal "X" and the concomitant crosslinking ofmIg.
Signal X is invoked because resting B cells do not present
DNP-OVA in the absence of an interaction with FDC, even
when the antigen is added at high concentrations (Table 1) .
And it is then revealed in circumstances ofFDC-B cell inter-
action that do not involve mIg, when the concentration of
exogenous DNP-OVA is high (Table 3) . While the nature
of signal X remains to be characterized, it likely involves the
facilitation of mIg-mediated endocytosis .
T Cells Need Not Interact with FDC .
￿
To assess whether
the observed T cell proliferation was dependent upon T cell
contact with the FDC, B cells and FDC were cocultured
for 24 h and then theFDC removed . This was accomplished
by vigorously pipetting the FDC-B cell clusters, followed
by removal ofFDC using the FDC-specific mAb, FDC-M1,
bound to Dynabeads . As shown in Table 4, adding the T-ova
clones 24 h after initiation of the FDC-B cell cocultures
resulted in levels of thymidine incorporation comparable to
those observed when all three components are added at the
onset of culture. Vigorous pipetting of cultures without
removing FDC resulted in slightly lower levels ofT cell acti-
vation, possibly due to cell damage incurred by this proce-
dure . Removal of FDC subsequent to pipetting further di-
minished T cell activation, although, as shown in Table 4,
the FDC-depleted population still produced a strong antigen-
specific T cell response. Thus, once the B cells have inter-
acted with FDC, the latter are not required for efficient T
cell-B cell interaction .
Phenotypic Characterization ofB Cells after Interaction with
FDC. In addition to the striking functional consequences
of FDC-B cell interactions, it was of interest to determine
whether associated changes in the B cell phenotype were in-
duced . Toward this end, cell size, as well as the level ofmem-
brane expression of both MHC class II and B7/BB1, were
assessed by flow cytometry. Expression ofMHC class II an-
tigens by cells in the FDC preparations was excluded since
these cells were obtained from the I-E-negative strain,
C57BL/6, and the analyses were done by gating on I-E-positive
cells . Anti-tc beads were used as a positive control for B cell
stimulation .
As illustrated in Fig. 2 A, an arbitrary gate, R2, was set
to measure increases in the forward and side light scatter
profiles, taken to represent B cell activation . That this is a
fair representation of the proportion of blasts in the popula-
tion is supported by the fact that the percentage of cells that
fall into this gate increases from 5.9% with resting B cells
to 33.8% upon anti-tc bead stimulation (Fig. 2 D) . The scatter
profile of restingB cells cocultured with FDC isolated from
mice hyper-immune with DNP-OVA indicates that the
efficiency of antigen-mediatedFDC-B cell interaction in the
induction of B cell blastogenesis approaches that of anti-tc
beads (Fig . 2 E) . Consistent with our other observations of
interactions not involving mIg, coculture ofB cells and FDC
from OVA-primed animals resulted in a lower but significant
induction of stimulation (Fig . 2 B) .
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Table 4 .
￿
Effect ofPreincubation of Resting and Activated
B Cells with FDCs on Antigen Presentation Capacity
Thymidine incorporation"
B cells and FDCs were irradiated with 1,000 rad before culture .
t The activated B cell preparation contained up to 90% B220+ cells and
<5% Mo and DC .
S All values represent the average of triplicate wells; all standard devia-
tions for these values fall within 10% of the mean .
II FDCs were isolated from DNP-OVA-immune C57BL/6 mice.
TB cells and FDCs were incubated together for 24 h and then the T
cell clones added .
" B cells andFDCs were incubated together for 24 hand then vigorously
pipeted to disrupt the cellular clusters . T cells were then added to three
of these wells .
$t Alternatively, after disruption of the FDC/B cell clusters, magnetic
Dynabeads coated with the anti-FDC mAb, FDC-Ml, were added to
the wells in order to deplete the FDCs . After a 30-min incubation, the
non-Dynabead-attached cells were removed and added to wells contain-
ingT cell clones .
Similar results were obtainedwhen the induction ofMHC
class II expression was assessed. FDC isolated from animals
immunized with either OVA or DNP-OVA supported in-
creasedMHC class II expression, with the FDC-DNP-OVA
doing so more effectively (Fig . 3) . Although no CD4+ or
CD8+ T cells were detectable in these cultures (Fig . 2, G
and H), the possibility that IL-4 was contributing to either
blastogenesis or increasedMHC class II expression could not
be formally excluded. However, when these experiments were
repeated using FDC-OVA or FDC-DNP-OVA populations
obtained from IL-4-deficient mice, identical results were ob-
tained (Figs. 2, C and F, and 3) .
B7/BB1 is a costimulatory molecule that is important for
APC function, and its expression is upregulated after B cell
activation (39) . We assessed the membrane expression of
B7/BB1 using a chimeric form ofits ligand : a fusion protein
ofCTLA-4 and the constant region ofhuman IgG1 . Resting
B cells cocultured for only 24 h with either FDC or anti-ic
beads did not detectably bind theCTLA-IgG1 construct (not
Resting B cells
(high density)
Activated B cellst
(low density)
cpm
Medium alone 7465 632
+ T cells 843 1,012
+ T cells + DNP-OVA 769 79,513
+ T cells + FDC-D-oll 63,224 66,576
+ FDC-D-oll 1,595 2,174
Pre-incubation :
+ FDC-D -o1/ + T cells 59,074 61,033
+ FDC-D-o"`/+ T cells 48,294 59,546
+ FDC-D -ott/+ T cells 22,617 40,298
Additional control
FDC-D-o + T cells 883shown) . However, within 48 h, expression ofB7 was induced
by either FDC-DNP-OVA or anti-rc beads (Fig . 4) . Cocul-
ture with FDC-OVA induced only a marginal upregulation
ofB7 expression, while culture with soluble DNP-OVA had
no detectable effect (Fig . 4) . The induction ofB7 by FDC-
DNP-OVA correlates well with the ability of these FDC to
induce B cell APC function. Further, the marginal effects
of coculture with FDC-OVA on B7 expression support the
conclusion that while non-antigen-specific FDC-B cell in-
teraction potentiates some APC functions in resting B cells,
the involvement ofmIg is clearly providing essential signals .
Discussion
In many experimental systems, resting B cells are relatively
poor APC (22-26) . They can, however, presentwhen provided
with antigens that crosslink their mIg receptors (31) . Fur-
thermore, stimulation of resting B cells with nonmitogenic
anti-Ig antibodies moves them into a state in which they can
very effectively process and present soluble antigens (43) . How
then do B cells present antigen in vivo? Thymus-dependent
antigens usually enter the lymph or bloodstream as mono-
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Figure 2 .
￿
Analysis of resting B
cell blastogenesis . A-Frepresent for-
ward vs . side scatter profiles of the
resting B cells in the presence orab-
sence ofantigen (DNP-OVA), fol-
licular dendritic cells (FDC), or
anti-K Ig-coated Sepharose beads
(K-beads) . To analyzeonly the B cell
population, the cells were labeled for
MHC class II using themAb 14.4.4,
which recognizes the IE expressed
by the B cells (isolated from
BALB/c) and is not expressed by the
FDC population (isolated from
C57BL/6) . As such, a gate (RI) was
set to analyze cells that were
medium to highly bright in their
expression ofIE .A second gate (R2)
was drawn on the forward and side
scatter profiles in order to quanti-
tate thenumber of cells that fall into
the larger, more activated pheno-
type. (A)HD B cells cultured with
10 ttg/ml DNP-OVA; (B) HD B
cells cultured withFDC from OVA-
immune C57BL/6 mice ; (C) HD
B cells cultured with FDC from
OVA-immune, I14-deficient trans-
genic C57BL/6 mice (IL4KO) ; (D)
HD B cells cultured with anti-aIg-
coated Sepharose beads; (E)HD B
cells culturedwithFDC from DNP-
OVA-immune C57BL/6 mice; (F)
HD B cells cultured withFDCfrom
DNP-OVA-immune, 11,4-deficient
transgenic C57BL/6 mice (IL4KO) .
G and H demonstrate the lack of
CD4- or CD8-positive T cells in the
HD B cell or FDC preparations,
respectively.
meric molecules, but may become complexed with preex-
isting, low affinity, crossreactive serum antibodies. These com-
plexes could then be rapidly localized onto the specialized
accessory cells of B cell follicles, namelyFDC. Previous studies
(44) have shown that the spacing of repeating antigenic epi-
topes on the surface of FDC are within the optimal range
required for stimulation of B cells (45). These characteris-
tics, together with their proven ability to support B cell
proliferation (35, 46-49), make the FDC a prime candidate
for the cell that primes resting B cells for interaction with
T cells .
The results presented in this study demonstrate that FDC
stimulate restingB cells in a manner that leads to their effec-
tive presentation of antigen to T cells . As a consequence of
their interaction with FDC, resting B cells undergo pheno-
typic changes that may explain their newly acquired capacity.
These changes involve alterations in cell size, an increase in
MHC class II expression, and the de novo expression of
B7/BB1, a molecule shown to provide a prerequisite costimula-
tory signal to T cells (39, 40) . While there is preliminary
evidence that crosslinking of mIg by antibodies induces an
increased rate ofmIg internalization (B . Stockinger, personalU
] 3
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communication), we have not determined if the interaction
withFDC has this effect . But it is evident from these studies
that crosslinking sIg does not account for all of the observed
effects . Although the induction ofB7 appears to require the
signaling through mIg, both changes inMHC class II and
the acquisition of the capacity to present soluble, specific an-
tigen added to the cultures occur in the presence of FDC
carrying antigens for which the B cells are not specific.
It is of obvious importance then to define the character
of the FDC-derived signals . Upregulation ofMHC class II
expression is known to occur after stimulation with anti-Ig
antibodies (28) with an augmentation in the presence of ID4
(50, 51) . However, as we have discussed, antigen-specific
receptor crosslinking does not fully explain the phenomena
in our system, and an obligatory role for IL-4 was ruled out
using IL-4-deficient mice. Signaling viaMHC class II mole-
cules themselves seems unlikely since FDC do not express
CD4 (15) . This mechanism cannot be entirely ruled out since
other molecules such as CD23 expressed by FDC (52) may
mediate the signal .
Figure 3.
￿
MHC class II level of expression vs. forward scatter profiles .
Resting B cells were cocultured for 24 h with the same populations de-
scribed in the legend to Fig . 2. Percentage of positive cells falling in the
top two quadrants are shown. The mAb 14 .4 .4, which recognizes only
IE molecules, was used in order to evaluate class II expression of the B
cells (obtained from a BALB/c background) . Since the FDC population
was obtained from the IE-negative C57BL/6 mouse strain, their contri-
bution to the analysis was avoided.
Figure 4.
￿
De novo expression of
B7/BB1 . The level of B7/BB1 ex-
pression on B cells after48 h ofcul-
ture . Resting Bcells werecocultured
in thepresence or absence ofDNP-
OVA (10 !Ag/ml; A), FDC from
mice immune toDNP-OVA (B) or
OVA (C), or anti-u beads (D) . The
level of B7/BBI was assessedusing
the chimeric fusion protein made
from the extracellular portion onthe
mouse CTLA-4 gene and the con-
stant region of the human IgGI
molecule.The most enticing idea involves the antigen-independent
effects of the immune complexes attached to FDC. In addi-
tion to antigen and antibody, various complement compo-
nents are involved that anchor the complexes into theFDC's
plasma membrane via CR1/CD35 and CR2/CD21 mole-
cules (15) . CD21(CR2), which binds C3dg, is also expressed
by B cells in a trimolecular complex together with CD19
and a moleculeknown as TAPA-1(53, 54) . Signaling via CD21
was implicated some time ago in the progression ofB cells
through cell cycle (55, 56) while more recently, others have
demonstrated that prior ligation of CD21 on B cells with
polymeric C3dg augmented the subsequent anti-Ig-mediated
proliferation (57) . The effect of ligation of CD21 with
membrane-bound CD23, one of its several natural ligands
(58), to our knowledge, has not yet been tested . Carter and
Fearon (59) more recently have extended their studies on the
function of the CD19-CD21-TAPA-1 complex. They showed
that antibody ligation ofCD19 at the same time asIgM reduces
the threshold concentration of anti-IgM required to induce
B cell proliferation by 100-fold . Since the natural ligand for
CD19 has not been determined to date, it is not implausible
that it could be expressed by FDC . In addition to these mol-
ecules, data are emerging concerning the costimulatory role
of antibodies to CD38 on mouse germinal center B cell
proliferation (M . Kosco-Vilbois andM . Parkhouse, unpub-
lished observations) .
The scheme that we would propose is that FDC "prime"
resting B cells for the subsequent antigen-specific, cognate
interaction with aT cell . The restricting event would there-
fore be between these two cells, requiring that the B cell not
only express the appropriate peptide/MHC complex, satis-
fying the T cell specificity, but in addition that it functions
as an APC. One might argue that FDC-primed B cells may
be able to take advantage ofT cell factors through a bystander
mechanism . However, the monoclonal nature of each ger-
minal center (4), and our previous data showing that lym-
References
phokines will not replace theT cell contact required to mimic
germinal center-like proliferation in vitro (35), argue against
nonspecific B cell proliferation and differentiation in this
microenvironment .
There are three stages oftheimmune response that should
be considered in the context of this study in assessing the
physiological relevance of our findings : (a) primary activa-
tion ofvirgin B cells ; (b) activation ofmemory B cell precursors
in germinal centers ; and (c) persistent stimulation ofmemory
B cells. The high density, resting B cells used in this study
are likely to contain at least two of these populations : the
virgin B cells and memory B cells. Several studies suggest
that in vivo the primary activation of virgin B cells occurs
outside the follicles, i .e ., virgin B cells do not gain access
to FDC . This is based upon the identification of the sites
of primary B cell proliferation (60, 61) and analysis of the
activation of virgin B cells after restriction of antigen toFDC
(62-64) . Neither of these observations rules out that a small
number of virgin B cell reach the locale of the FDC to be
"primed" for T cell interaction . Indeed, these may be the
B cells that give rise to the germinal center. While Linton
et al . (65) have called such memory precursors a separate lin-
eage, itmay be a stochastic process that leads to the prolifera-
tion of a subset ofB cells in germinal centers. When forced
to interact with FDC in vitro, it may be that all B cells can
enter this pathway. It is difficult to argue that contact with
FDC is important for the primary activation of all virgin
B cells, but we would propose that "FDC priming" is a pre-
lude to differentiation along the memory cell pathway, in-
cluding isotype switching and somatic hypermutation . It is
an open question whether recirculating memory B cells ever
return to a small, dense resting state. However, if they do
they would have access to FDC. It has already become clear
that interaction with antigen-coated FDC is required for con-
tinued memory B cell survival (19, 66) .
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